Uncategorized
Expert Outlook: Guidewire Software Through The Eyes Of 15 Analysts
Latest Ratings for GWRE Date Firm Action From To Mar 2022 Wells Fargo Maintains Underweight Dec 2021 BTIG Maintains Buy Oct 2021 B of A Securities Downgrades Neutral Underperform View More Analyst Ratings for GWRE View the Latest Analyst Ratings read more
Options Corner: CrowdStrike Gains Relevance As Iran Poses Cyber Retaliation Threat
Amid a dramatic escalation in the Middle East, CrowdStrike’s cybersecurity business has been thrust into the spotlight, boosting CRWD stock. read more
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
Septerna gains Buy rating as HC Wainwright highlights undervaluation, strong pipeline, and key partnership with Novo Nordisk in metabolic diseases. read more
Stock Of The Day: Is Lululemon Ready To Rebound?
lululemon athletica (LULU) has been in a steep downtrend. But now it it oversold and at support. It may reverse and head higher. read more
Why Active Fixed-Income ETFs Quietly Dominate In 2025
Actively managed fixed-income ETFs have pulled in a staggering $82.09 billion in net inflows year-to-date. Here’s why. read more
Can FedEx Deliver? Q4 Earnings Put Turnaround Hopes To The Test As Market Strategist Looks For ‘Any Sustained Rebound’
FedEx could deliver a market jolt with its Q4 report — if the company sticks the landing on earnings and guidance read more
Ocugen (OCGN) Shares Slide Following Merger Agreement: What’s Going On?
Shares of Ocugen are trading lower Monday afternoon. The company earlier announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics. read more